Sort
48,018 grants matching “immunotherapy”
Structural and Functional Characterization of Allergens
$363,894Robert E London · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
$363,877Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
The development of Saccharomyces (yeast) vaccines for cancer therapy
$363,871James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$363,871James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Project 2: Immunotherapy with CMP-001 intratumoral and nivolumab in melanoma
$363,864Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2021 · CA
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
$363,863Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P50 · FY2021 · CA
Project 3: Localized microneedle-directed combination immunotherapy for cSCC
$363,863Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2021 · CA
Structural Immunology of Classical and Non-classical MHC
$363,853Ian A Wilson · Scripps Research Institute, The · R01 · FY2008 · CA
Augmenting T cell activity to weak tumor antigens and reversing myeloid cell-mediated T cell inhibition
$363,833Eduardo Davila · University Of Maryland Baltimore · R01 · FY2017 · CA
Immunopathogenesis of Allergic Aspergillosis
$363,816Saint Louis University · R21 · FY2003 · AI
Quantitative and Spatially-Resolved Analysis of the Tumor Immune Contexture for Optimal Diagnosis and Treatment of Lung Cancer
$363,815Kurt A Schalper · Yale University · R37 · FY2024 · CA
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms
$363,801Katherine B Chiappinelli · George Washington University · R37 · FY2023 · CA
Role of B-cell mediated anti-tumor antibodies in responses to radiation and immunotherapy in HNSCC
$363,793Andrew B. Sharabi · University Of California, San Diego · R01 · FY2022 · DE
Immune regulation of the B7-H1 pathway
$363,788Johns Hopkins University · R01 · FY2005 · CA
T Cell Regulation of Cutaneous Malignancy
$363,788Yale University · R01 · FY2005 · CA
Immune regulation of the B7-H1 pathway
$363,788Johns Hopkins University · R01 · FY2004 · CA
Antigen Specific Immunotherapy with Transduced HSC
$363,788Johns Hopkins University · R01 · FY2004 · CA
Antigen Specific Immunotherapy with Transduced HSC
$363,788Johns Hopkins University · R01 · FY2003 · CA
Antigen Specific Immunotherapy with Transduced HSC
$363,788Johns Hopkins University · R01 · FY2005 · CA
T Cell Regulation of Cutaneous Malignancy
$363,788Yale University · R01 · FY2003 · CA
T Cell Regulation of Cutaneous Malignancy
$363,788Yale University · R01 · FY2004 · CA
Novel ways to prevent upper GT infection
$363,782Kathleen A. Kelly · University Of California Los Angeles · R01 · FY2013 · AI
Defining the effects of bortezomib on NK cell activation in cancer
$363,750Anil Shanker · Meharry Medical College · SC1 · FY2013 · CA
Defining the effects of bortezomib on NK cell activation in cancer
$363,750Anil Shanker · Meharry Medical College · SC1 · FY2016 · CA
Defining the effects of bortezomib on NK cell activation in cancer
$363,750Anil Shanker · Meharry Medical College · SC1 · FY2015 · CA